New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
10:00 EDTRADRite Aid benefiting from generic rebid and Cymbalta launch, says Cleveland
Cleveland Research said Rite Aid's gross profits are benefiting from a recent RFP for its generic business which will likely result in savings of 3% and the Cymbalta generic launch that is running above expectations, which should offset reimbursement pressures.
News For RAD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 13, 2014
14:50 EDTRADLonestar Capital to shut down by mid-2015, WSJ reports
Subscribe for More Information
14:45 EDTRADLonestar capital to shut down, DJ reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use